Explore our materials

Filters

Results (13891)

Slideset

HIV

INTEREST 2016

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Stephen Watiti

Slideset

HIV

INTEREST 2016

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD

François Venter

MD, FCP, PhD

Slideset

HIV

INTEREST 2016

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Speaker for the Opposition | François Venter, MD, FCP, PhD

Slideset

HIV

INTEREST 2016

New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed

Slideset

HIV

INTEREST 2016

Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD

Slideset

HIV

INTEREST 2016

Sustaining progress on scale-up of voluntary medical male circumcision (VMMC), including role of devices and early infant male circumcision | Zebedee Mwandi, MD

Slideset

HIV

INTEREST 2016

(Abstract) Factors associated with virologic failure in HIV infected individuals in Mansa district, Zambia | G. Mutaawe

Slideset

HIV

INTEREST 2016

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma

Slideset

HIV

INTEREST 2016

(Abstract) Retention in care among HIV-infected pregnant mothers on lifelong antiretroviral therapy (art) in Uganda | S. Muhumuza

Slideset

HIV

INTEREST 2016

(Abstract) Getting pregnant in antiretroviral clinical trials: women choice and safety needs. Experience from the ANRS12169-2LADY and ANRS12286- MOBIDIP trials | A. Serris

Slideset

HIV

INTEREST 2016

(Abstract) Maximizing EID opportunities using the DBS Mentor Approach in Rural HIV Clinics in South-Eastern Nigeria | P. Anyanwu

Slideset

HIV

INTEREST 2016

Explore our materials

Your Selection Clear All

Topic

Material Type

(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Community Advocate | Stephen Watiti, MD

Debate: Gilead: The Continent of Africa is Ready for HIV Pre-Exposure Prophylaxis (PreP) Implementation | Speaker for the Opposition | François Venter, MD, FCP, PhD

New evidence on oral and topical PrEP for women: rings, gels, injectables | Nyaradzo Mgodi, MBChB, MMed

Dolutegravir in contributing the 90:90:90 ambition | Tuna Lukiana MD, PhD

Sustaining progress on scale-up of voluntary medical male circumcision (VMMC), including role of devices and early infant male circumcision | Zebedee Mwandi, MD

(Abstract) Factors associated with virologic failure in HIV infected individuals in Mansa district, Zambia | G. Mutaawe

(Abstract) Immunologic Criteria are Poor Predictors of Virologic Outcomes: Implications for HIV Monitoring in a Large Treatment Program in Nigeria | J. Okuma

(Abstract) Retention in care among HIV-infected pregnant mothers on lifelong antiretroviral therapy (art) in Uganda | S. Muhumuza

(Abstract) Getting pregnant in antiretroviral clinical trials: women choice and safety needs. Experience from the ANRS12169-2LADY and ANRS12286- MOBIDIP trials | A. Serris

(Abstract) Maximizing EID opportunities using the DBS Mentor Approach in Rural HIV Clinics in South-Eastern Nigeria | P. Anyanwu

(Abstract) Model-based pediatric dosing of ritonavir-boosted Darunavir: an alternative to WHO guidelines | P. Mohammed